Pacira Biosciences' net profit under GAAP for 9 months of 2020 was $131.008 million, against a loss of $6.128 million in the previous year. Revenue increased 0% to $298.673 million, against $298.602 million in the previous year.
Pacira Biosciences' net profit under GAAP for 9 months of 2020 was $131.008 million, against a loss of $6.128 million in the previous year. Revenue increased 0% to $298.673 million, against $298.602 million in the previous year. 
investor.pacira.com
English (US) 